The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally

Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro, Ceu Figueiredo, Erika Ruiz, Maria Alsina, Cristina Molero, Marcelo Garrido, Arnoldo Riquelme, Carmelo Caballero, Eva Lezcano, Juan Manuel O’Connor, Federico Esteso, Judith Farrés, José Manuel Mas, Florian Lordick, Jeannette Vogt, Antonella Cardone, Charis Girvalaki, Andrés Cervantes, Tania Fleitas, Unknown

Open source

DOI
10.1186/s12885-022-09689-9
Published
2022-06-13
Container
BMC Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-022-09689-9,
  title = {The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally},
  author = {Tessa Suzanne van Schooten and Sarah Derks and Elena Jiménez-Martí and Fatima Carneiro and Ceu Figueiredo and Erika Ruiz and Maria Alsina and Cristina Molero and Marcelo Garrido and Arnoldo Riquelme and Carmelo Caballero and Eva Lezcano and Juan Manuel O’Connor and Federico Esteso and Judith Farrés and José Manuel Mas and Florian Lordick and Jeannette Vogt and Antonella Cardone and Charis Girvalaki and Andrés Cervantes and Tania Fleitas and Unknown},
  year = {2022},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-022-09689-9},
  url = {https://doi.org/10.1186/s12885-022-09689-9}
}

RIS

TY  - JOUR
TI  - The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally
AU  - Tessa Suzanne van Schooten
AU  - Sarah Derks
AU  - Elena Jiménez-Martí
AU  - Fatima Carneiro
AU  - Ceu Figueiredo
AU  - Erika Ruiz
AU  - Maria Alsina
AU  - Cristina Molero
AU  - Marcelo Garrido
AU  - Arnoldo Riquelme
AU  - Carmelo Caballero
AU  - Eva Lezcano
AU  - Juan Manuel O’Connor
AU  - Federico Esteso
AU  - Judith Farrés
AU  - José Manuel Mas
AU  - Florian Lordick
AU  - Jeannette Vogt
AU  - Antonella Cardone
AU  - Charis Girvalaki
AU  - Andrés Cervantes
AU  - Tania Fleitas
AU  - Unknown
PY  - 2022
JO  - BMC Cancer
DO  - 10.1186/s12885-022-09689-9
UR  - https://doi.org/10.1186/s12885-022-09689-9
ER  - 

APA

Schooten, T. S. V., Derks, S., Jiménez-Martí, E., Carneiro, F., Figueiredo, C., Ruiz, E., Alsina, M., Molero, C., Garrido, M., Riquelme, A., Caballero, C., Lezcano, E., O’Connor, J. M., Esteso, F., Farrés, J., Mas, J. M., Lordick, F., Vogt, J., Cardone, A., Girvalaki, C., Cervantes, A., Fleitas, T., & Unknown (2022). The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally. BMC Cancer. https://doi.org/10.1186/s12885-022-09689-9

Source records